On July 23, the Reagan-Udall Foundation, in cooperation with FDA, held a public meeting to gather input on the clinical use and safety concerns associated with orally ingestible unapproved prescription drug products containing fluoride for use in children.

The Reagan-Udall Foundation (RUF) has released its Roadmap to Produce Safety: Summary of the Produce Safety Dialogue, which reflects input from produce sector stakeholders and is intended to serve as a “foundation for transformative change in produce safety management through collaboration.”

FDA’s new Rare Disease Innovation Hub and Office of Regulatory and Emerging Diseases are addressing some of the issues, but neither has the resources nor authority to comprehensively approach the unique patient impact of chronic progressive diseases. A good approach would be for FDA or the patient community to seek the help of the Reagan-Udall Foundation for the FDA.

The MOU is aligned with FDA's goals in the new Reagan-Udall Foundation's Roadmap to Produce Safety, which advocates for a shared responsibility to food safety between the public and private sectors, driven by structured, stakeholder-led collaborations.

FDA is calling on produce industry leaders to spearhead a sector-wide transformation in produce safety.